BIOLASE, Inc. Responds to Shareholder Inquiries
(firmenpresse) - IRVINE, CA -- (Marketwired) -- 06/06/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, announced today that its Board of Directors has issued the following statement in response to inquiries from a significant number of shareholders:
There is absolutely no truth to rumors that Federico Pignatelli, Chairman and CEO, would resign from the Board or the Company. Mr. Pignatelli is and will remain Chairman and CEO, as he was elected in August, 2010. He is fully engaged in all aspects of the Company's business, as he will continue to be.
Mr. Pignatelli stated, "I am fully committed to Biolase now and for the future."
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and . The Company's laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers.
Other products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase® and laser dentistry, find BIOLASE® online at , Facebook at , Twitter at , Pinterest at , LinkedIn at , Instagram at and YouTube at .
BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.
For further information, please contact:
Michael Porter
Porter, LeVay & Rose, Inc.
212-564-4700
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.06.2013 - 16:07 Uhr
Sprache: Deutsch
News-ID 267389
Anzahl Zeichen: 2647
contact information:
Town:
IRVINE, CA
Kategorie:
Dentistry
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BIOLASE, Inc. Responds to Shareholder Inquiries"
steht unter der journalistisch-redaktionellen Verantwortung von
BIOLASE, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
